Knowledge, attitude, future expectations and perceived barriers of medical students and physicians regarding pharmacogenomics in Jordan

被引:14
作者
Alzoubi, Abdallah [1 ]
Kanaan, Hashem [2 ]
Alhazaimeh, Dua'a [2 ]
Gharaibeh, Salam [1 ]
Mukattash, Tareq L. [3 ]
Kheirallah, Khalid [2 ]
机构
[1] Jordan Univ Sci & Technol, Dept Pharmacol, Fac Med, POB 3030, Irbid 22110, Jordan
[2] Jordan Univ Sci & Technol, Fac Med, Dept Publ Hlth & Community Med, Irbid, Jordan
[3] Jordan Univ Sci & Technol, Fac Pharm, Dept Clin Pharm, Irbid, Jordan
关键词
ADVERSE DRUG-REACTIONS; CLINICAL VALIDITY; LESSONS;
D O I
10.1111/ijcp.13658
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Pharmacogenomics (PG) is a modern tool of personalising treatment protocols to improve the efficacy and safety of drug prescriptions. These benefits are offset by a slow uptake in clinical application due to a host of physician factors, patient factors and/or health system factors. Our study, thus, aimed to determine the knowledge, attitude, future expectations and perceived barriers of medical students and physicians in Jordan regarding PG testing. Methods A descriptive, cross-sectional study was conducted between February and August 2019. Physicians and senior medical students from academic and non-academic institutions in North Jordan (n = 424) were surveyed. A structured, self-administered questionnaire was designed and piloted for the purpose of the study. A scoring system for each dimension assessed was calculated and presented using means. Mean scores were compared by sociodemographic and professional variables. Results The response rate was 70.7%. The mean total PG knowledge score (+/- SD) was 5.42 (+/- 1.51) out of 10, with a significantly higher mean among respondents aged <30 years (5.54 +/- 1.43) compared with those >= 30 years old (5.21 +/- 1.62;P = .03). The mean total PG attitude score was 21.18 (+/- 2.58) out of 24, with significant differences by seniority levels evident (P = .03). The future expectations of PG among our sample were high, with a mean score of 10.44 (+/- 1.64) out of 12. The top three perceived barriers in applying PG were the high cost, lack of clinical guidelines, and limited knowledge and awareness. Conclusion Physicians and medical students in Jordan have low overall knowledge, albeit strongly positive attitude and future expectations towards PG, despite the perceived high cost and lack of clinical guidelines. Thus, we strongly recommend adopting a comprehensive educational strategy that aims to integrate PG concepts into medical curricula, and promote the culture of continuous medical education about PG among practitioners.
引用
收藏
页数:7
相关论文
共 43 条
[21]   Identifying aberrant pathways through integrated analysis of knowledge in pharmacogenomics [J].
Hoehndorf, Robert ;
Dumontier, Michel ;
Gkoutos, Georgios V. .
BIOINFORMATICS, 2012, 28 (16) :2169-2175
[22]   EFFECTS OF CULTURE AND RESPONSE FORMAT ON EXTREME RESPONSE STYLE [J].
HUI, CH ;
TRIANDIS, HC .
JOURNAL OF CROSS-CULTURAL PSYCHOLOGY, 1989, 20 (03) :296-309
[23]  
Jarrar YB., 2019, Jordan Med J, V53, P81
[24]   Incidence of adverse drug reactions in hospitalized patients - A meta-analysis of prospective studies [J].
Lazarou, J ;
Pomeranz, BH ;
Corey, PN .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (15) :1200-1205
[25]   Roles of pharmacogenomics in non-anthracycline antineoplastic-induced cardiovascular toxicities: A systematic review and meta-analysis of genotypes effect [J].
Leong, Siew Lian ;
Chaiyakunapruk, Nathorn ;
Tassaneeyakul, Wichittra ;
Arunmanakul, Poukwan ;
Nathisuwan, Surakit ;
Lee, Shaun Wen Huey .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 280 :190-197
[26]  
Lowitt MH, 2001, ARCH DERMATOL, V137, P1512
[27]   Pharmacogenomic Testing: Knowing More, Doing Better [J].
Lunshof, J. E. ;
Gurwitz, D. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 (03) :387-389
[28]   The interface between pharmacoepidemiology and pharmacogenetics [J].
Maitland-van der Zee, AH ;
de Boer, A ;
Leufkens, HGM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 410 (2-3) :121-130
[29]  
Muzoriana N, 2017, PHARMACY, V5, DOI 10.3390/pharmacy5030036
[30]   Personalized medicine: new genomics, old lessons [J].
Offit, Kenneth .
HUMAN GENETICS, 2011, 130 (01) :3-14